Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the last

Clin Cancer Res. 2005 Jul 1;11(13):4639-43. doi: 10.1158/1078-0432.CCR-05-0973.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • ADAM Proteins / metabolism*
  • ADAM17 Protein
  • Antineoplastic Agents / therapeutic use
  • Epidermal Growth Factor / metabolism*
  • Female
  • Heparin-binding EGF-like Growth Factor
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Lysophospholipids / physiology*
  • Models, Biological
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / physiopathology
  • Signal Transduction / drug effects

Substances

  • Antineoplastic Agents
  • HBEGF protein, human
  • Heparin-binding EGF-like Growth Factor
  • Intercellular Signaling Peptides and Proteins
  • Lysophospholipids
  • Epidermal Growth Factor
  • ADAM Proteins
  • ADAM17 Protein
  • lysophosphatidic acid